MOVING SCIENCE FORWARD

OUR SCIENCE

Novel compounds targeting key driver of edema in several clinical indications

Aquaporin 4 (AQP4) inhibitors based on novel structure-based inhibitor design

PARTNERING

Our relationships with our partners allow us to build prospective pipelines as well as evaluate new technologies that augment our discovery and development initiatives.

OUR PIPELINE

Screening campaign yielded multiple highly potent AQP4 inhibitors
Compounds have opportunity to treat several edema-related disorders